BioSpace News Archive

The Angiogenesis Foundation reports that new research published in the New England Journal of Medicine shows that the respiratory virus SARS-CoV-2, which causes COVID-19, causes severe damage to blood vessels, leading to widespread thrombosis, or blood clotting, in the lung.

Cigna customers have expanded access to mental health support online and via text messaging to help cope with the impact of COVID-19 and improve overall well-being

Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository, a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.

Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients’ lives

PPD, Inc., a leading global contract research organization, announced that it intends to offer $700 million in aggregate principal amount of senior notes, subject to market and other conditions.

Devonian Health Group Inc., a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced the nomination of Dr Andre P. Boulet, PhD, as representative of Canada within the American Botanical Drug Association.

AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.

Companion Medical, the producers of InPen, the only FDA-cleared reusable smart insulin pen system, announced that co-founder and CEO, Sean Saint, has been named as one of the Top 50 Healthcare Technology CEOs of 2020 by The Healthcare Technology Report.

Primary endpoint met with confirmation of drug’s safety and tolerability Strong effects on secondary endpoints on activity markers and disease progression Improvement or stabilisation across different measures of motor function & strength Activity on the targeted CD49d immune cells consistent with drug’s proposed mechanism of action New MRI data suggests stabilisation of percentage of fat in muscles and preservatio

After years of continued success in their field, Revelox is bringing their signature product line to the Efficient Collaborative Retail Marketing conference for ECRM’s historic virtual expo, May 18th through May 21st.